Cargando…
NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment
OBJECTIVE: 3-iodothyronamine (T(1)AM), an analog of thyroid hormone, is a recently discovered fast-acting endogenous metabolite. High single dose treatments of T(1)AM have produced rapid short-term effects, including a reduction of body temperature, bradycardia, and hyperglycemia in mice. DESIGN AND...
Autores principales: | Haviland, J. A., Reiland, H., Butz, D. E., Tonelli, M., Porter, W. P., Zucchi, R., Scanlan, T. S., Chiellini, G., Assadi-Porter, F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692609/ https://www.ncbi.nlm.nih.gov/pubmed/23512955 http://dx.doi.org/10.1002/oby.20391 |
Ejemplares similares
-
Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression
por: Assadi-Porter, Fariba M., et al.
Publicado: (2018) -
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
por: Selen Alpergin, Ebru S., et al.
Publicado: (2017) -
Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
por: Rogowski, Michael, et al.
Publicado: (2019) -
Protein Catabolism and High Lipid Metabolism Associated with Long-Distance Exercise Are Revealed by Plasma NMR Metabolomics in Endurance Horses
por: Le Moyec, Laurence, et al.
Publicado: (2014) -
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
por: Polini, Beatrice, et al.
Publicado: (2023)